Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | SPN | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
mRNA | IRAK4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
mRNA | DAZL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | RP11-234B24.6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | MTURN | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | FAM83D | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | C16orf92 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | ZNF439 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
mRNA | KIAA1143 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |